Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zerocube
    Junior Member
    • Aug 2015
    • 2

    #1

    454 Junior Sequencing kit

    Hi everyone
    Recently Roche decided to terminate support for 454 junior and all the family of 454 pyrosequencer. I work in a large italian hospital and I use junior to sequence HIV's RT, protease and integrase gene for assenssing HAART.
    Does anyone knows if there are in the world any other qualified producer for 454 sequencing kit reactives?
    Thanks in advance for any response!
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    #2
    Originally posted by zerocube View Post
    Hi everyone
    Recently Roche decided to terminate support for 454 junior and all the family of 454 pyrosequencer.
    They first announced this in October 2013.
    Manufacturing of 454 sequencers will continue through 2015, and the sequencers will continue to be serviced through mid-2016...
    I'd hardly call that recent; on the time scale of Next Generation Sequencing that's a generation ago.

    I'm sure there is a lot of patent protected intellectual property that goes into the 454 reagents and Roche is unlikely to license it to a third party. More to the point it seems bit risky to continue to use an officially unsupported platform for diagnostic testing.

    Comment

    • pmiguel
      Senior Member
      • Aug 2008
      • 2328

      #3
      454/Roche Applied Sciences, had evidently lobotomized itself prior to their decision to market a desktop solution, rather than continue slugging it out on the big platform side with Illumina about, what, 5 years ago?

      You should be able to pick up an Ion Torrent (PGM or something of that ilk) at a very low cost. Wouldn't that be the way to go?
      --
      Phillip

      Comment

      • zerocube
        Junior Member
        • Aug 2015
        • 2

        #4
        kmcarr your post will not help. I don't care about how and when Roche decided to rule out 454, I only need kits. I hope you don't sequence like you reply to post because you completely failed the target.

        pmiguel I agree with you about Roche's lobotomy, i'm afraid that i'll be forced to fall back to Ion torrent

        Comment

        • ECO
          --Site Admin--
          • Oct 2007
          • 1360

          #5
          This is a bummer...just tweeted a link to this thread to try to help.

          Comment

          • DNA_Dan
            Member
            • Nov 2008
            • 21

            #6
            How big are your targets? We cover small HIV regions on a MiSeq 600 cycle kit and can multiplex up to 384 samples in a single run using the Nextera XT adapters.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              Yesterday, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 02:55 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Working...